{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T04:25:46Z","timestamp":1790915146214,"version":"4.1.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2004,10,16]],"date-time":"2004-10-16T00:00:00Z","timestamp":1097884800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                        <jats:title>Background<\/jats:title>\n                        <jats:p>Pneumocystis pneumonia (PCP) is an increasing problem amongst patients on immunosuppression with autoimmune inflammatory disorders (AID). The disease presents acutely and its diagnosis requires bronchoalveolar lavage in most cases. Despite treatment with intravenous antibiotics, PCP carries a worse prognosis in AID patients than HIV positive patients. The overall incidence of PCP in patients with AID remains low, although patients with Wegener's granulomatosis are at particular risk.<\/jats:p>\n                     <\/jats:sec><jats:sec>\n                        <jats:title>Discussion<\/jats:title>\n                        <jats:p>In adults with AID, the risk of PCP is related to treatment with systemic steroid, ill-defined individual variation in steroid sensitivity and CD4+ lymphocyte count. Rather than opting for PCP prophylaxis on the basis of disease or treatment with cyclophosphamide, we argue the case for carrying out CD4+ lymphocyte counts on selected patients as a means of identifying individuals who are most likely to benefit from PCP prophylaxis.<\/jats:p>\n                     <\/jats:sec><jats:sec>\n                        <jats:title>Summary<\/jats:title>\n                        <jats:p>Corticosteroids, lymphopenia and a low CD4+ count in particular, have been identified as risk factors for the development of PCP in adults with AID. Trimethoprim-sulfamethoxazole (co-trimoxazole) is an effective prophylactic agent, but indications for its use remain ill-defined. Further prospective trials are required to validate our proposed prevention strategy.<\/jats:p>\n                     <\/jats:sec>","DOI":"10.1186\/1471-2334-4-42","type":"journal-article","created":{"date-parts":[[2004,10,21]],"date-time":"2004-10-21T06:24:15Z","timestamp":1098339855000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":85,"title":["Autoimmune inflammatory disorders, systemic corticosteroids and pneumocystis pneumonia: A strategy for prevention"],"prefix":"10.1186","volume":"4","author":[{"given":"Evin","family":"Sowden","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew J","family":"Carmichael","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2004,10,16]]},"reference":[{"key":"127_CR1","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1590\/S0074-02761909000200008","volume":"1","author":"C Chagas","year":"1909","unstructured":"Chagas C: Nova trypanozomiaza humana. Estudos sobre a morfolojia e o ciclo evolutivo do Schizotrypanum cruzi n. gen., n. sp. Ajente etilogio de nova entidade morbida de homen. Mem Inst Oswaldo Cruz Rio de J. 1909, 1: 159-218.","journal-title":"Mem Inst Oswaldo Cruz Rio de J"},{"key":"127_CR2","first-page":"1774","volume":"69","author":"O Goetz","year":"1974","unstructured":"Goetz O, Peller P: Pneumocystis-carinii-Pneumonien. Ubersichten Med Klin. 1974, 69: 1774-1778.","journal-title":"Ubersichten Med Klin"},{"key":"127_CR3","doi-asserted-by":"publisher","first-page":"705","DOI":"10.7326\/0003-4819-96-6-705","volume":"96","author":"SE Follansbee","year":"1982","unstructured":"Follansbee SE, Busch DF, Wofsy CB, Coleman DL, Gullet J, Aurigemma GP, Ross T, Hadley WK, Drew WL: An outbreak of Pneumocystis carinii pneumonia in homosexual men [abstract]. Ann Intern Med. 1982, 96: 705-13.","journal-title":"Ann Intern Med"},{"key":"127_CR4","doi-asserted-by":"publisher","first-page":"891","DOI":"10.3201\/eid0809.020096","volume":"8","author":"JR Stringer","year":"2002","unstructured":"Stringer JR, Beard CB, Miller RF, Wakefield AE: A New Name (Pneumocystis jiroveci) for Pneumocystis from Humans. Emerg Infect Dis. 2002, 8: 891-896.","journal-title":"Emerg Infect Dis"},{"key":"127_CR5","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.4049\/jimmunol.140.6.2023","volume":"140","author":"JA Kovacs","year":"1988","unstructured":"Kovacs JA, Halpern JL, Swan JC, Moss J, Parrillo JE, Masur H: Identification of antigens and antibodies specific for Pneumocystis carinii [abstract]. J Immunol. 1988, 140: 2023-31.","journal-title":"J Immunol"},{"key":"127_CR6","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1016\/0140-6736(90)92008-6","volume":"336","author":"AE Wakefield","year":"1990","unstructured":"Wakefield AE, Pixley FJ, Banerji S, Sinclair K, Miller RF, Moxon ER, et al: Detection of Pneumocystis carinii with DNA amplification [abstract]. Lancet. 1990, 336: 451-453. 10.1016\/0140-6736(90)92008-6.","journal-title":"Lancet"},{"key":"127_CR7","doi-asserted-by":"publisher","first-page":"265","DOI":"10.3201\/eid0603.000306","volume":"6","author":"CB Beard","year":"2000","unstructured":"Beard CB, Carter JL, Keely SP, Huang L, Pieniazek NJ, Moura IN, et al: Genetic variation in Pneumocystis carinii isolates from different geographic regions: implications for transmission. Emerg Infect Dis. 2000, 6: 265-272.","journal-title":"Emerg Infect Dis"},{"key":"127_CR8","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1093\/qjmed\/91.12.813","volume":"91","author":"J Helweg-Larsen","year":"1998","unstructured":"Helweg-Larsen J, Tsolaki AG, Miller RF, Lundgren B, Wakefield AE: Clusters of Pneumocystis carinii pneumonia: analysis of person-to-person transmission by genotyping. QJM. 1998, 91: 813-820. 10.1093\/qjmed\/91.12.813.","journal-title":"QJM"},{"key":"127_CR9","doi-asserted-by":"publisher","first-page":"132","DOI":"10.3201\/eid0901.020141","volume":"9","author":"ES Manoloff","year":"2003","unstructured":"Manoloff ES, Francioli P, Taffe P, Melle GV, Bille J, Hauser PM: Risk for Pneumocystis carinii Transmission among Patients with Pneumonia: a Molecular Epidemiology Study. Emerg Infect Dis. 2003, 9: 132-134.","journal-title":"Emerg Infect Dis"},{"key":"127_CR10","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1128\/JCM.38.4.1536-1538.2000","volume":"38","author":"SL Vargas","year":"2000","unstructured":"Vargas SL, Ponce CA, Gigliotti F, Ulloa AV, Prieto S, Munoz MP, Hughes WT: Transmission of Pneumocystis carinii DNA from a Patient with P. carinii Pneumonia to Immunocompetent Contact Health Care Workers. J Clin Microbiol. 2000, 38: 1536-1538.","journal-title":"J Clin Microbiol"},{"key":"127_CR11","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1128\/jcm.34.7.1754-1759.1996","volume":"34","author":"AE Wakefield","year":"1996","unstructured":"Wakefield AE: DNA sequences identical to Pneumocystis carinii f. sp. Carinii and Pneumocystis carinii f. sp. Hominis in samples of air spora. J Clin Microbiol. 1996, 34: 1754-1759.","journal-title":"J Clin Microbiol"},{"key":"127_CR12","doi-asserted-by":"publisher","first-page":"28S","DOI":"10.1111\/j.1550-7408.1997.tb05752.x","volume":"44","author":"L Casanova-Cardiel","year":"1997","unstructured":"Casanova-Cardiel L, Leibowitz MJ: Presence of Pneumocystis carinii DNA in pond water [abstract]. J Eukaryot Microbiol. 1997, 44: 28S-","journal-title":"J Eukaryot Microbiol"},{"key":"127_CR13","first-page":"96","volume":"8","author":"S Safrin","year":"1993","unstructured":"Safrin S: Pneumocystis carinii pneumonia in patients with the acquired immunodeficiency syndrome [abstract]. Semin Respir Infect. 1993, 8: 96-103.","journal-title":"Semin Respir Infect"},{"key":"127_CR14","doi-asserted-by":"crossref","first-page":"233","DOI":"10.5694\/j.1326-5377.1995.tb139873.x","volume":"162","author":"JG Gerrard","year":"1995","unstructured":"Gerrard JG: Pneumocystis carinii pneumonia in HIV-negative immunocompromised adults [abstract]. Med J Aust. 1995, 162: 233-235.","journal-title":"Med J Aust"},{"key":"127_CR15","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1007\/s10096-002-0758-5","volume":"21","author":"F Roblot","year":"2002","unstructured":"Roblot F, Godet C, Le Moal G, Garo B, Faouzi Souala M, Dary M, De Gentile L, Gandji JA, Guimard Y, Lacroix C, Roblot P, Becq-Giraudon B: Analysis of underlying diseases and prognosis factors associated with Pneumocystis carinii pneumonia in immunocompromised HIV-negative patients [abstract]. Eur J Clin Microbiol Infect Dis. 2002, 21: 523-31. 10.1007\/s10096-002-0758-5.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"127_CR16","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.1086\/313534","volume":"29","author":"R Nuesch","year":"1999","unstructured":"Nuesch R, Bellini C, Zimmerli W: Pneumocystis carinii pneumonia in human immunodeficiency virus (HIV)-positive and HIV-negative immunocompromised patients. Clin Infect Dis. 1999, 29: 1519-23. 10.1086\/313534.","journal-title":"Clin Infect Dis"},{"key":"127_CR17","doi-asserted-by":"publisher","first-page":"5","DOI":"10.4065\/71.1.5","volume":"71","author":"SH Yale","year":"1996","unstructured":"Yale SH, Limper AH: Pneumocystis carinii pneumonia in patients without acquired immunodeficiency syndrome: associated illness and prior corticosteroid therapy [abstract]. Mayo Clin Proc. 1996, 71: 5-13.","journal-title":"Mayo Clin Proc"},{"key":"127_CR18","doi-asserted-by":"publisher","first-page":"2436","DOI":"10.1001\/archinte.1995.00430220094010","volume":"155","author":"SM Arend","year":"1995","unstructured":"Arend SM, Kroon FP, van't Wout JW: Pneumocystis carinii pneumonia in patients without AIDS, 1980 through 1993. An analysis of 78 cases [abstract]. Arch Intern Med. 1995, 155: 2436-2441. 10.1001\/archinte.155.22.2436.","journal-title":"Arch Intern Med"},{"key":"127_CR19","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1378\/chest.118.3.712","volume":"118","author":"NG Mansharamani","year":"2000","unstructured":"Mansharamani NG, Balachandran D, Vernovsky I, Garland R, Koziel H: Peripheral blood CD4 + T-lymphocyte counts during Pneumocystis carinii pneumonia in immunocompromised patients without HIV infection. Chest. 2000, 118: 712-720. 10.1378\/chest.118.3.712.","journal-title":"Chest"},{"key":"127_CR20","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1128\/CMR.4.2.137","volume":"4","author":"MS Bartlett","year":"1991","unstructured":"Bartlett MS, Smith JW: Pneumocystis carinii, an opportunist in immunocompromised patients. Clin Microbiol Rev. 1991, 4: 137-49.","journal-title":"Clin Microbiol Rev"},{"key":"127_CR21","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1093\/rheumatology\/37.6.659","volume":"37","author":"W Koldingsnes","year":"1998","unstructured":"Koldingsnes W, Gran JT, Omdal R, Husby G: Wegener's granulomatosis: long-term follow-up of patients treated with pulse cyclophosphamide. Br J Rheumatol. 1998, 37: 659-664. 10.1093\/rheumatology\/37.6.659.","journal-title":"Br J Rheumatol"},{"key":"127_CR22","first-page":"246","volume":"21","author":"B Godeau","year":"1994","unstructured":"Godeau B, Coutant-Perronne V, Le Thi Huong D, Guillevin L, Magadur G, De Bandt M, Dellion S, Rossert J, Rostoker G, Piette JC, et al: Pneumocystis carinii pneumonia in the course of connective tissue disease: report of 34 cases [abstract]. J Rheumatol. 1994, 21: 246-251.","journal-title":"J Rheumatol"},{"key":"127_CR23","doi-asserted-by":"crossref","first-page":"2432","DOI":"10.1128\/jcm.28.11.2432-2436.1990","volume":"28","author":"P Cregan","year":"1990","unstructured":"Cregan P, Yamamoto A, Lum A, VanDerHeide T, MacDonald M, Pulliam L: Comparison of four methods for rapid detection of Pneumocystis carinii in respiratory specimens. J Clin Microbiol. 1990, 28: 2432-2436.","journal-title":"J Clin Microbiol"},{"key":"127_CR24","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1007\/BF01967503","volume":"9","author":"M Orholm","year":"1990","unstructured":"Orholm M, Holten-Andersen W, Lundgren JD: Improved detection of Pneumocystis carinii by an immunofluorescence technique using monoclonal antibodies [abstract]. Eur J Clin Microbiol Infect Dis. 1990, 9: 880-885.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"127_CR25","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1097\/00005792-198709000-00002","volume":"66","author":"DB Hellmann","year":"1987","unstructured":"Hellmann DB, Petri M, Whiting-O'Keefe Q: Fatal infections in systemic lupus erythematosus: the role of opportunistic organisms [abstract]. Medicine (Baltimore). 1987, 66: 341-348.","journal-title":"Medicine (Baltimore)"},{"key":"127_CR26","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1128\/AAC.34.4.499","volume":"34","author":"RT Davey Jr","year":"1990","unstructured":"Davey RT, Masur H: Recent Advances in the Diagnosis, Treatment, and Prevention of Pneumocystis carinii Pneumonia. Antimicrob Agents Chemother. 1990, 34: 499-504.","journal-title":"Antimicrob Agents Chemother"},{"key":"127_CR27","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1002\/1529-0131(199904)42:4<780::AID-ANR23>3.0.CO;2-M","volume":"42","author":"MM Ward","year":"1999","unstructured":"Ward MM, Donald F: Pneumocystis carinii pneumonia in patients with connective tissue diseases: the role of hospital experience in diagnosis and mortality [abstract]. Arthritis Rheum. 1999, 42: 780-789. 10.1002\/1529-0131(199904)42:4<780::AID-ANR23>3.3.CO;2-D.","journal-title":"Arthritis Rheum"},{"key":"127_CR28","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.1001\/archinte.1997.00440340145015","volume":"157","author":"H Bachelez","year":"1997","unstructured":"Bachelez H, Schremmer B, Cadranel J, Mouly F, Sarfati C, Agbalika F, Schlemmer B, Mayaud CM, Dubertret L: Fulminant Pneumocystis carinii pneumonia in 4 patients with dermatomyositis [abstract]. Arch Intern Med. 1997, 157: 1501-1503. 10.1001\/archinte.157.13.1501.","journal-title":"Arch Intern Med"},{"key":"127_CR29","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1017\/S0950268801005507","volume":"126","author":"TL Lamagni","year":"2001","unstructured":"Lamagni TL, Evans BG, Shigematsu M, Johnson EM: Emerging trends in the epidemiology of invasive mycoses in England and Wales (1990\u20139) [abstract]. Epidemiol Infect. 2001, 126: 397-414. 10.1017\/S0950268801005507.","journal-title":"Epidemiol Infect"},{"key":"127_CR30","first-page":"795","volume":"151","author":"FP Ognibene","year":"1995","unstructured":"Ognibene FP, Shelhamer JH, Hoffman GS, Kerr GS, Reda D, Fauci AS, Leavitt RY: Pneumocystis carinii pneumonia: a major complication of immunosuppressive therapy in patients with Wegener's granulomatosis [abstract]. Am J Respir Crit Care Med. 1995, 151: 795-799.","journal-title":"Am J Respir Crit Care Med"},{"key":"127_CR31","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1046\/j.1365-2133.1999.03052.x","volume":"141","author":"SP Raychaudhuri","year":"1999","unstructured":"Raychaudhuri SP, Siu S: Pneumocystis carinii pneumonia in patients receiving immunosuppressive drugs for dermatological diseases [abstract]. Br J Dermatol. 1999, 141: 528-530. 10.1046\/j.1365-2133.1999.03052.x.","journal-title":"Br J Dermatol"},{"key":"127_CR32","first-page":"1191","volume":"19","author":"AJ Porges","year":"1992","unstructured":"Porges AJ, Beattie SL, Ritchlin C, Kimberly RP, Christian CL: Patients with systemic lupus erythematosus at risk for Pneumocystis carinii pneumonia [abstract]. J Rheumatol. 1992, 19: 1191-1194.","journal-title":"J Rheumatol"},{"key":"127_CR33","doi-asserted-by":"publisher","first-page":"4149","DOI":"10.1210\/jc.84.11.4149","volume":"84","author":"SD Hearing","year":"1999","unstructured":"Hearing SD, Norman M, Smyth C, Foy C, Dayan CM: Wide variation in lymphocyte steroid sensitivity among healthy human volunteers. J Clin Endocrinol Metab. 1999, 84: 4149-4154. 10.1210\/jc.84.11.4149.","journal-title":"J Clin Endocrinol Metab"},{"key":"127_CR34","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1136\/ard.54.12.991","volume":"54","author":"B Godeau","year":"1995","unstructured":"Godeau B, Mainardi JL, Roudot-Thoraval F, Hachulla E, Guillevin L, Huong Du LT, Jarrousse B, Remy P, Schaeffer A, Piette JC: Factors associated with Pneumocystis carinii pneumonia in Wegener's granulomatosis [abstract]. Ann Rheum Dis. 1995, 54: 991-994.","journal-title":"Ann Rheum Dis"},{"key":"127_CR35","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1136\/bmj.2.5091.265","volume":"34","author":"EW Walton","year":"1958","unstructured":"Walton EW: Giant-cell granuloma of the respiratory tract (Wegener's granulomatosis). Br Med J. 1958, 34: 265-270.","journal-title":"Br Med J"},{"key":"127_CR36","doi-asserted-by":"publisher","first-page":"488","DOI":"10.7326\/0003-4819-116-6-488","volume":"116","author":"GS Hoffman","year":"1992","unstructured":"Hoffman GS, Kerr GS, Leavitt RY, Hallahan CW, Lebovics RS, Travis WD, Rottem M, Fauci AS: Wegener granulomatosis: an analysis of 158 patients. Ann Intern Med. 1992, 116: 488-498.","journal-title":"Ann Intern Med"},{"key":"127_CR37","first-page":"1186","volume":"23","author":"A Kadoya","year":"1996","unstructured":"Kadoya A, Okada J, Iikuni Y, Kondo H: Risk factors for Pneumocystis carinii pneumonia in patients with polymyositis\/dermatomyositis or systemic lupus erythematosus [abstract]. J Rheumatol. 1996, 23: 1186-1188.","journal-title":"J Rheumatol"},{"key":"127_CR38","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1056\/NEJM199001183220304","volume":"322","author":"J Phair","year":"1990","unstructured":"Phair J, Munoz A, Detels R, Kaslow R, Rinaldo C, Saah A: The risk of Pneumocystis carinii pneumonia among men infected with human immunodeficiency virus type 1. Multicenter AIDS Cohort Study Group. N Engl J Med. 1990, 322: 161-165.","journal-title":"N Engl J Med"},{"key":"127_CR39","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.1086\/313478","volume":"29","author":"G Nevez","year":"1999","unstructured":"Nevez G, Raccurt C, Vincent P, Jounieaux V, Dei-Cas E: Pulmonary colonization with Pneumocystis carinii in human immunodeficiency virus-negative patients: assessing risk with blood CD4+ T cell counts. Clin Infect Dis. 1999, 29: 1331-1332. 10.1086\/313478.","journal-title":"Clin Infect Dis"},{"key":"127_CR40","doi-asserted-by":"publisher","first-page":"1705","DOI":"10.1128\/AAC.35.9.1705","volume":"35","author":"DS Stein","year":"1991","unstructured":"Stein DS, Stevens RC, Terry D, Laizure SC, Palte S, Lancaster DJ, Weems JJ, Williams CL: Use of low-dose trimethoprim-sulfamethoxazole thrice weekly for primary and secondary prophylaxis of Pneumocystis carinii pneumonia in human immunodeficiency virus-infected patients. Antimicrob Agents Chemother. 1991, 35: 1705-1709.","journal-title":"Antimicrob Agents Chemother"},{"key":"127_CR41","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1056\/NEJM197712292972602","volume":"297","author":"WT Hughes","year":"1977","unstructured":"Hughes WT, Kuhn S, Chaudhary S, Feldman S, Verzosa M, Aur RJ, Pratt C, George SL: Successful chemoprophylaxis for Pneumocystis carinii pneumonitis [abstract]. N Engl J Med. 1977, 297: 1419-1426.","journal-title":"N Engl J Med"},{"key":"127_CR42","doi-asserted-by":"publisher","first-page":"1627","DOI":"10.1056\/NEJM198706253162604","volume":"316","author":"WT Hughes","year":"1987","unstructured":"Hughes WT, Rivera GK, Schell MJ, Thornton D, Lott L: Successful intermittent chemoprophylaxis for Pneumocystis carinii pneumonitis [abstract]. N Engl J Med. 1987, 316: 1627-1632.","journal-title":"N Engl J Med"},{"key":"127_CR43","doi-asserted-by":"publisher","first-page":"435","DOI":"10.7326\/0003-4819-137-5_Part_2-200209031-00002","volume":"137","author":"H Masur","year":"2002","unstructured":"Masur H, Kaplan JE, Holmes KK, U.S. Public Health Service; Infectious Diseases Society of America: Guidelines for preventing opportunistic infections among HIV-infected persons \u2013 2002. Recommendations of the U.S. Public Health Service and the Infectious Diseases Society of America. Ann Intern Med. 2002, 137: 435-478.","journal-title":"Ann Intern Med"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2334-4-42.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2334-4-42\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2334-4-42","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2334-4-42.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,7]],"date-time":"2024-10-07T12:43:11Z","timestamp":1728304991000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/1471-2334-4-42"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,10,16]]},"references-count":43,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2004,12]]}},"alternative-id":["127"],"URL":"https:\/\/doi.org\/10.1186\/1471-2334-4-42","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,10,16]]},"assertion":[{"value":"2 June 2004","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 October 2004","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 October 2004","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"42"}}